Ciprofloxacin



Combined with:

Yaz

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 27.7%
Urinary Tract Infection 20.3%
Drug Use For Unknown Indication 12.5%
Infection 6.8%
Pneumonia 3.2%
Diverticulitis 2.8%
Cystitis 2.6%
Lower Respiratory Tract Infection 2.6%
Prostatitis 2.6%
Unevaluable Event 2.5%
Sinusitis 2.3%
Bronchitis 2.0%
Prophylaxis 2.0%
Hypertension 1.8%
Cellulitis 1.7%
Pain 1.6%
Pseudomonas Infection 1.4%
Sepsis 1.2%
Pyrexia 1.2%
Kidney Infection 1.1%
Tendonitis 13.5%
Vomiting 9.8%
Tendon Rupture 9.7%
Tendon Pain 7.1%
Renal Failure Acute 5.6%
Rash 5.6%
Pain In Extremity 4.9%
Urticaria 4.3%
Rhabdomyolysis 4.2%
Tremor 3.7%
Tendon Disorder 3.6%
Weight Decreased 3.5%
Paraesthesia 3.5%
Toxic Epidermal Necrolysis 3.4%
Drug Interaction 3.3%
Tinnitus 3.1%
Urinary Tract Infection 3.0%
Pyrexia 2.8%
Mania 2.7%
Treatment Failure 2.7%
Secondary
Product Used For Unknown Indication 35.3%
Drug Use For Unknown Indication 12.7%
Urinary Tract Infection 7.8%
Hypertension 5.8%
Pneumonia 5.6%
Infection 4.1%
Prophylaxis 3.2%
Drug Abuse 3.0%
Hiv Infection 2.7%
Pyrexia 2.3%
Bronchitis 2.2%
Bacteraemia 2.1%
Pain 2.0%
Sinusitis 2.0%
Pseudomonas Infection 1.7%
Staphylococcal Infection 1.6%
Diarrhoea 1.5%
Osteomyelitis 1.5%
Ill-defined Disorder 1.4%
Depression 1.4%
Vomiting 14.5%
Tendon Rupture 10.7%
Tendonitis 8.1%
Toxic Epidermal Necrolysis 7.6%
Renal Failure Acute 7.2%
Drug Hypersensitivity 6.8%
Urinary Tract Infection 5.3%
Rotator Cuff Syndrome 5.1%
Stevens-johnson Syndrome 4.2%
Weight Decreased 3.6%
Toxic Skin Eruption 3.3%
Drug Ineffective 2.9%
Pyrexia 2.8%
Visual Acuity Reduced 2.8%
Renal Failure 2.7%
Rhabdomyolysis 2.7%
Drug Rash With Eosinophilia And Systemic Symptoms 2.5%
Loss Of Consciousness 2.5%
Pain In Extremity 2.5%
Tendon Disorder 2.5%
Concomitant
Product Used For Unknown Indication 31.7%
Drug Use For Unknown Indication 12.9%
Prophylaxis 8.9%
Pain 5.8%
Crohn's Disease 5.0%
Hypertension 4.5%
Multiple Myeloma 3.7%
Nausea 2.7%
Infection 2.5%
Hiv Infection 2.3%
Depression 2.3%
Acute Myeloid Leukaemia 2.3%
Constipation 2.2%
Contraception 2.0%
Urinary Tract Infection 2.0%
Breast Cancer 2.0%
Infection Prophylaxis 2.0%
Anxiety 1.8%
Prophylaxis Of Nausea And Vomiting 1.7%
Pneumonia 1.6%
Vomiting 11.9%
Urinary Tract Infection 8.2%
Weight Decreased 7.8%
Sepsis 6.4%
Pyrexia 6.2%
Thrombocytopenia 6.2%
Pneumonia 5.9%
Pulmonary Embolism 5.3%
White Blood Cell Count Decreased 5.3%
Pain 5.2%
Renal Failure Acute 4.4%
Death 3.7%
Febrile Neutropenia 3.3%
Nausea 3.3%
Septic Shock 3.3%
Respiratory Failure 3.1%
Renal Failure 2.9%
Drug Ineffective 2.6%
Tachycardia 2.5%
Deep Vein Thrombosis 2.5%
Interacting
Product Used For Unknown Indication 27.6%
Drug Use For Unknown Indication 10.2%
Mental Disorder 8.2%
Urinary Tract Infection 7.0%
Hypertension 5.3%
Leukocytosis 5.1%
Periorbital Cellulitis 3.4%
Atrial Fibrillation 3.2%
Pneumonia 3.1%
Infection 2.9%
Chronic Obstructive Pulmonary Disease 2.7%
Endocarditis Bacterial 2.7%
Pain 2.7%
Bladder Pain 2.6%
Lung Transplant 2.6%
Pyrexia 2.6%
Pulmonary Embolism 2.4%
Chest Pain 2.0%
Procedural Pain 1.9%
Convulsion 1.7%
Drug Interaction 18.2%
Renal Failure Acute 10.7%
Weight Decreased 8.3%
International Normalised Ratio Increased 5.8%
Myalgia 5.8%
Homicide 5.0%
Hypoglycaemia 5.0%
Petechiae 5.0%
Rhabdomyolysis 5.0%
Electrocardiogram Qt Prolonged 4.1%
Pyrexia 4.1%
Intraocular Pressure Increased 3.3%
Penis Disorder 3.3%
Tremor 3.3%
Bronchitis 2.5%
Miosis 2.5%
Respiratory Tract Infection Bacterial 2.5%
Torsade De Pointes 2.5%
Blood Pressure Decreased 1.7%
Clostridium Difficile Colitis 1.7%